载脂蛋白B/载脂蛋白A-I比值在统计学上是比传统血脂谱更好的心血管疾病（CVD）预测指标：来自尼泊尔加德满都谷地的一项研究。
Apo B/Apo A-I Ratio is Statistically A Better Predictor of Cardiovascular Disease (CVD) than Conventional Lipid Profile: A Study from Kathmandu Valley, Nepal.
作者信息
Tamang Hem Kumar, Timilsina Uddhav, Singh Khelanand Prasad, Shrestha Sanjit, Raman Ramendra Kumar, Panta Pujan, Karna Preeti, Khadka Laxmi, Dahal Chandika
机构信息
Lecturer, Department of Biochemistry, Kantipur Dental College Teaching Hospital , Dhapasi, Basundhara, Kathamandu, Nepal .
Phd Scholar, Department of Life Sciences and Biotechnology, South Asian University , New Delhi, India .
出版信息
J Clin Diagn Res. 2014 Feb;8(2):34-6. doi: 10.7860/JCDR/2014/7588.4000. Epub 2014 Feb 3.
Abstract
BACKGROUND
Apo B and Apo A-I, are structural and functional components of lipoprotein particles that serve as transporters of cholesterol. The apo B/apo A-I ratio reflects the cholesterol transport and has been shown to be strongly related to risk of Myocardial infarction, stroke and other Cardiovascular manifestations.
MATERIALS AND METHODS
Forty five participants with Cardiovascular Disease (CVD) and forty four healthy participants were included from different locations of Kathmandu valley, Nepal. Fasting blood samples were collected from ante-cubital vein and serum samples were used for lipid parameters, apo B and apo A-I levels measurement.
RESULTS
Statistically significant differences were found for apo B/apo A-I ratio, HDL-c and apo B between the groups. The other lipid parameters and lipid ratios such as total cholesterol, triglyceride, low density lipoprotein, TC/HDL-c, TG/HDL-c and LDL-c/HDL-c were not found to be significant.
CONCLUSION
Apo B/apo A-I ratio seems to have better predictive value than that of classical lipid parameters in cardiovascular risk assessment.
摘要
背景
载脂蛋白B（Apo B）和载脂蛋白A-I（Apo A-I）是脂蛋白颗粒的结构和功能成分，充当胆固醇的转运体。Apo B/Apo A-I比值反映胆固醇转运情况，且已证明与心肌梗死、中风及其他心血管表现的风险密切相关。
材料与方法
从尼泊尔加德满都谷地的不同地点纳入45名心血管疾病（CVD）参与者和44名健康参与者。从前臂肘正中静脉采集空腹血样，血清样本用于脂质参数、Apo B和Apo A-I水平测量。
结果
两组之间在Apo B/Apo A-I比值、高密度脂蛋白胆固醇（HDL-c）和Apo B方面存在统计学显著差异。未发现其他脂质参数和脂质比值（如总胆固醇、甘油三酯、低密度脂蛋白、总胆固醇/高密度脂蛋白胆固醇、甘油三酯/高密度脂蛋白胆固醇和低密度脂蛋白胆固醇/高密度脂蛋白胆固醇）有显著差异。
结论
在心血管风险评估中，Apo B/Apo A-I比值似乎比传统脂质参数具有更好的预测价值。
相似文献
1
Apo B/Apo A-I Ratio is Statistically A Better Predictor of Cardiovascular Disease (CVD) than Conventional Lipid Profile: A Study from Kathmandu Valley, Nepal.载脂蛋白B/载脂蛋白A-I比值在统计学上是比传统血脂谱更好的心血管疾病（CVD）预测指标：来自尼泊尔加德满都谷地的一项研究。
J Clin Diagn Res. 2014 Feb;8(2):34-6. doi: 10.7860/JCDR/2014/7588.4000. Epub 2014 Feb 3.
2
Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-I, apo B, and malondialdehyde in hyperlipidemic patients.高脂血症患者同时服用维生素C和ω-3脂肪酸对脂蛋白、载脂蛋白A-I、载脂蛋白B和丙二醛影响的比较
Int J Vitam Nutr Res. 2003 May;73(3):163-70. doi: 10.1024/0300-9831.73.3.163.
3
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.不同血脂指标对男性和女性冠心病预测的临床效用。
JAMA. 2007 Aug 15;298(7):776-85. doi: 10.1001/jama.298.7.776.
4
Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.非肥胖和肥胖多囊卵巢综合征患者的脂蛋白和同型半胱氨酸水平。
Gynecol Endocrinol. 2005 May;20(5):258-63. doi: 10.1080/09513590400027265.
5
Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels.甘油三酯浓度对脂蛋白胆固醇与载脂蛋白B及A-I水平之间关系的影响。
Metabolism. 2000 Jan;49(1):53-61. doi: 10.1016/s0026-0495(00)90688-7.
6
Relevance of the triglyceride-to-high-density lipoprotein cholesterol ratio as an important lipid fraction in apparently healthy, young, and middle-aged Indian men.甘油三酯与高密度脂蛋白胆固醇比值作为明显健康的年轻及中年印度男性重要血脂成分的相关性
Indian J Endocrinol Metab. 2017 Jan-Feb;21(1):113-118. doi: 10.4103/2230-8210.196020.
7
A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL₃+IDL]).在 >50 岁行冠状动脉造影的女性中，一种新的比值（载脂蛋白 A1 残基比 [VLDL₃+IDL]）优于标准血脂测量，可更好地预测未来的死亡/心肌梗死：载脂蛋白 A1 残基比（Apo A1/ [VLDL₃+IDL]）。
Lipids Health Dis. 2013 Apr 26;12:55. doi: 10.1186/1476-511X-12-55.
8
Beneficial changes in serum apo A-1 and its ratio to apo B and HDL in stable hyperlipidaemic subjects after Ramadan fasting in Kuwait.科威特斋月禁食后，稳定型高脂血症患者血清载脂蛋白A-1及其与载脂蛋白B和高密度脂蛋白比值的有益变化。
Eur J Clin Nutr. 2000 Jun;54(6):508-13. doi: 10.1038/sj.ejcn.1601047.
9
Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.血浆脂质、载脂蛋白与冠状动脉疾病之间的关联：一项针对低风险韩国人群的横断面研究。
Int J Cardiol. 2005 Jun 8;101(3):435-40. doi: 10.1016/j.ijcard.2004.03.057.
10
Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.阿托伐他汀对糖尿病血液透析患者血脂谱及非传统心血管危险因素的影响。
Nephron Clin Pract. 2003;95(4):c128-35. doi: 10.1159/000074838.
引用本文的文献
1
Getting to the Heart of the Matter: Exploring the Intersection of Cardiovascular Disease, Sex and Race and How Exercise, and Gut Microbiota Influence these Relationships.直击问题核心：探索心血管疾病、性别与种族的交叉点，以及运动和肠道微生物群如何影响这些关系。
Rev Cardiovasc Med. 2025 Feb 20;26(2):26430. doi: 10.31083/RCM26430. eCollection 2025 Feb.
2
Decoding the Lipid-Angiogram Link: Can Serum Lipid Profile Help Predict Your Clogged Arteries?解读脂质与血管造影的关联：血清脂质谱能否帮助预测动脉堵塞情况？
Cureus. 2024 Nov 11;16(11):e73454. doi: 10.7759/cureus.73454. eCollection 2024 Nov.
3
Maternal Supraphysiological Hypercholesterolemia Is Accompanied by Shifts in the Composition and Anti-Atherogenic Functions of Maternal HDL along with Maternal Cardiovascular Risk Markers at Term of Pregnancy.孕期母体超生理水平的高胆固醇血症伴随着母体高密度脂蛋白（HDL）的组成和抗动脉粥样硬化功能的改变，以及孕期足月时母体心血管风险标志物的变化。
Antioxidants (Basel). 2023 Sep 27;12(10):1804. doi: 10.3390/antiox12101804.
4
The Ketogenic Diet and Cardiovascular Diseases.生酮饮食与心血管疾病。
Nutrients. 2023 Jul 28;15(15):3368. doi: 10.3390/nu15153368.
5
Lipid Biomarkers and Atherosclerosis-Old and New in Cardiovascular Risk in Childhood.脂类生物标志物与动脉粥样硬化——儿童心血管风险的新老问题。
Int J Mol Sci. 2023 Jan 23;24(3):2237. doi: 10.3390/ijms24032237.
6
Economics of Artificial Intelligence in Healthcare: Diagnosis vs. Treatment.医疗保健领域人工智能的经济学：诊断与治疗
Healthcare (Basel). 2022 Dec 9;10(12):2493. doi: 10.3390/healthcare10122493.
7
The Effect of Untraditional Lipid Parameters in the Development of Coronary Artery Disease: Atherogenic Index of Plasma, Atherogenic Coefficient and Lipoprotein Combined Index.非传统血脂参数在冠状动脉疾病发生发展中的作用：血浆致动脉粥样硬化指数、致动脉粥样硬化系数及脂蛋白综合指数
J Saudi Heart Assoc. 2021 Sep 20;33(3):244-250. doi: 10.37616/2212-5043.1266. eCollection 2021.
8
Therapeutic effects of an aspalathin-rich green rooibos extract, pioglitazone and atorvastatin combination therapy in diabetic db/db mice.富含 aspalathin 的南非路易波士茶提取物、吡格列酮和阿托伐他汀联合治疗糖尿病 db/db 小鼠的疗效。
PLoS One. 2021 May 13;16(5):e0251069. doi: 10.1371/journal.pone.0251069. eCollection 2021.
9
Effects of Acute Cocoa Supplementation on Postprandial Apolipoproteins, Lipoprotein Subclasses, and Inflammatory Biomarkers in Adults with Type 2 Diabetes after a High-Fat Meal.急性可可补充对 2 型糖尿病成人高脂餐后餐后载脂蛋白、脂蛋白亚类和炎症生物标志物的影响。
Nutrients. 2020 Jun 27;12(7):1902. doi: 10.3390/nu12071902.
10
Immune-Mediated Inflammation Promotes Subclinical Atherosclerosis in Recent-Onset Psoriatic Arthritis Patients without Conventional Cardiovascular Risk Factors.免疫介导的炎症促进了无传统心血管危险因素的发病近期银屑病关节炎患者亚临床动脉粥样硬化。
Front Immunol. 2018 Feb 26;9:139. doi: 10.3389/fimmu.2018.00139. eCollection 2018.
本文引用的文献
1
Apo-B/AI ratio identifies cardiovascular risk in childhood: the Australian Aboriginal Birth Cohort study.载脂蛋白 B/载脂蛋白 AI 比值可识别儿童期心血管风险：澳大利亚原住民出生队列研究。
Diab Vasc Dis Res. 2009 Apr;6(2):94-9. doi: 10.1177/1479164109336046.
2
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.《2001年全球和区域疾病负担及风险因素：对人群健康数据的系统分析》
Lancet. 2006 May 27;367(9524):1747-57. doi: 10.1016/S0140-6736(06)68770-9.
3
Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies.载脂蛋白B、载脂蛋白AI、载脂蛋白B/AI比值与冠心病之间的关联：基于文献的前瞻性研究荟萃分析。
J Intern Med. 2006 May;259(5):481-92. doi: 10.1111/j.1365-2796.2006.01644.x.
4
Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels.载脂蛋白AI和载脂蛋白B血浆水平的测量及意义。
J Intern Med. 2006 May;259(5):437-46. doi: 10.1111/j.1365-2796.2006.01648.x.
5
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.载脂蛋白B与胆固醇在评估心血管风险及指导治疗中的作用：三十人/十个国家专家小组报告
J Intern Med. 2006 Mar;259(3):247-58. doi: 10.1111/j.1365-2796.2006.01616.x.
6
MDGs: chronic diseases are not on the agenda.千年发展目标：慢性病未被列入议程。
Lancet. 2005;366(9496):1512-4. doi: 10.1016/S0140-6736(05)67610-6.
7
Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery disease.
Int J Cardiol. 2005 Jul 20;102(3):477-85. doi: 10.1016/j.ijcard.2004.05.056.
8
Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.血浆脂质、载脂蛋白与冠状动脉疾病之间的关联：一项针对低风险韩国人群的横断面研究。
Int J Cardiol. 2005 Jun 8;101(3):435-40. doi: 10.1016/j.ijcard.2004.03.057.
9
Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.载脂蛋白B和A-I在预测中老年男性和女性心肌梗死中的预后价值：来自莫妮卡/科拉奥格斯堡队列研究的结果
Eur Heart J. 2005 Feb;26(3):271-8. doi: 10.1093/eurheartj/ehi003. Epub 2004 Nov 30.
10
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.52个国家中与心肌梗死相关的潜在可改变风险因素的影响（INTERHEART研究）：病例对照研究
Lancet. 2004;364(9438):937-52. doi: 10.1016/S0140-6736(04)17018-9.
Zotero 插件